EnGene’s $60M PIPE; AbbVie to develop neuropsychiatric drugs with Gedeon Richter

Plus, news about Tectonic Therapeutic, Molecular Partners and Arcus Biosciences:

EnGene snags $60M: The Boston and Montreal gene therapy biotech

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‘Cell therapy without cells’: Capstan raises $175M to test in vivo CAR-T

Laura Shawver pictures a world 10 years from now where cell therapies are replaced by in vivo CAR-T products. The goal is a cheaper-to-produce, less

March 21, 2024

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis – Pharmaceutical Technology

Roche’s Ocrevus is currently offered on the NHS via twice-yearly intravenous (IV) infusions. Image credit: Shutterstock / Tong_stocker. England’s National Health Service (NHS) has said

July 12, 2024

Drug inspector attrition leads to ‘many fewer’ checks than 2016 peak, GAO says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.